Literature DB >> 1357677

NMDA enhances the central depressant properties of ethanol in mice.

A P Ferko1.   

Abstract

Male Swiss-Webster mice were used to examine the effect of NMDA on the ethanol-induced loss of the righting reflex (LORR). The LORR was used as a measure of CNS depression. Immediately after animals regained the righting reflex following ethanol injection (4.0 g/kg, IP) mice received an ICV injection of saline or NMDA (10, 50, 100, or 500 nmol/kg) in a volume of 5 microliters. Upon ICV injection of NMDA, mice again lost the righting reflex and this effect of NMDA in the presence of ethanol occurred rapidly and in a dose-dependent manner. In another experiment DL-2-amino-5-phosphonovaleric acid (APV), a competitive antagonist of NMDA, was given ICV with NMDA (50 nmol/kg) in the presence of ethanol. APV (10 and 100 nmol/kg, ICV) significantly attenuated the response of NMDA to enhance the depressant action of ethanol. When bicuculline methiodide, an antagonist of GABA, was given ICV with NMDA (50 nmol/kg), bicuculline methiodide reduced the effect of NMDA to produce a second loss of the righting reflex (return to the LORR) in the presence of ethanol. When NMDA (100 nmol/kg, ICV) was injected in the absence of ethanol into mice, NMDA by itself did not produce a loss of the righting reflex. In this investigation, the results suggest that NMDA can augment ethanol-induced depression possibly through an interaction between glutamatergic and GABAergeric systems in the CNS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357677     DOI: 10.1016/0091-3057(92)90671-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Investigations into pharmacological antagonism of general anaesthesia.

Authors:  H J Little; A Clark; W P Watson
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Measurement by in vivo brain microdialysis of nitric oxide release in the rat cerebellum.

Authors:  F Shintani; S Kanba; T Nakaki; K Sato; G Yagi; R Kato; M Asai
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.